Grant of Options

09 June 2014: Sphere Medical Holding plc (AIM: SPHR.L) (“Sphere Medical” or the “Company”), a leading developer of innovative monitoring and diagnostic products for the critical care setting, has today granted share options as follows:

Director No. of share options Exercise price
Dr. Wolfgang Rencken, CEO  1,320,000 (note 1) 40 pence
Matthew Hall, CFO  275,000 (note 2) 40 pence

 

Notes

1.Wolfgang Rencken - 625,000 share options were issued under the Company’s Enterprise Management Incentive Scheme and 695,000 share options were issued under the Company’s Unapproved Share Option Scheme.

2.Matthew Hall - 275,000 share options were issued under the Company’s Enterprise Management Incentive Scheme.

All share options referred to are exercisable overordinary shares of 1 pence each in the share capital of the Company (“Ordinary Shares”). These share options are subject to vesting conditions, a minimum holding period of five years from grant and have been issued at a premium of 48.1% to the 27 pence per Ordinary Share being the closing mid-market price for the Ordinary Shares on 5 June 2014. The issue of these share options has been approved by the Company’s Remuneration Committee.